[Expression of aFGF in ovarian epithelial cancer and its signal transduction pathway]

Yi Zhang1, Li-guang Sun, Hai Shang

  • 1Department of Gynecology, First Affiliated Hospital of China Medical University, Shenyang 110001, China.

Zhonghua Yi Xue Za Zhi
|August 6, 2003
PubMed
Abstract

Insights

Acidic fibroblast growth factor (aFGF) and its receptor FGFR1 are overexpressed in ovarian epithelial cancer, potentially driving tumor progression. Inhibition of tyrosine-specific protein phosphorylation by Genistein suppressed intracellular PKC and ERK activity in CAOV3 cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Context:

  • Ovarian epithelial cancer is a significant health concern with complex molecular underpinnings.
  • Acidic fibroblast growth factor (aFGF) and its receptor FGFR1 are implicated in various cancers.
  • Understanding signaling pathways is crucial for developing targeted therapies.

Purpose:

  • To investigate the expression of aFGF and FGFR1 in ovarian epithelial cancer.
  • To examine the impact of aFGF and the tyrosine-specific protein kinase (TPK) inhibitor Genistein on intracellular protein kinase C (PKC) and extracellular signal-regulated kinase (ERK) activity.
  • To explore the role of these molecules in ovarian cancer cell line CAOV3.

Summary:

  • RT-PCR and Western blot analysis revealed significant overexpression of aFGF and FGFR1 in ovarian epithelial cancer tissues, particularly in advanced stages (III-IV).
  • aFGF stimulation dose-dependently increased intracellular PKC and ERK activity in CAOV3 cells.
  • Genistein effectively suppressed PKC and ERK activity in a dose-dependent manner, indicating TPKs are upstream of these pathways in CAOV3 cells.

Impact:

  • The findings suggest aFGF plays a critical role in the carcinogenesis, development, and invasion of ovarian epithelial cancer.
  • The study highlights the potential of targeting the aFGF/FGFR1 pathway and downstream kinases (PKC, ERK) for therapeutic intervention.
  • This research provides insights into the molecular mechanisms underlying ovarian cancer progression and identifies potential therapeutic targets.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...